Does Hormone Replacement Therapy Increase the Risk of Breast Cancer?

February 25th, 2011

Since so many of our MigreLief friends and customers are women, I wanted to express my concern about the use of estrogen replacement therapy by perimenopausal and menopausal women. 
To me at least, the research data is fairly clear, hormone replacement therapy increases the risk of, at least, breast cancer. 
 
A recent study published in the Journal of the National Cancer Institute, which was based upon 4 million person-years of follow-up, in 1.1 million women, found the following:
 
1- Both current and past users of hormone replacement therapy were at significantly higher cancer risk than “never-users” and risk increased with the number of years hormone replacement therapy was used.
 
2- The risk was greater among current users if therapy started before or soon after menopause, compared with starting later;
 
3-The greatest risk was among current users of estrogen-progestin formulations;
 
4-Risk declined rapidly after stopping use, falling to that of never users within 3 years.
 
I suggest that women who are troubled by peri-menopausal symptoms try herbs like Chasteberry (aka -Vitex agnus cactus/Chaste Tree Extract) and/ or black cohosh to try to control their symptoms.
 
These options work very well for many women.  If they don’t work for you and you feel the need to take hormone replacement therapy, I suggest that you look into bio-identical hormones administered by a physician who is also trained in Alternative Medicine.
 
I strongly suggest that women on HRT discuss with their physician supplementing with calcium d-glucarate (200 mg) and Indole-3- carbinol (200 mg).  These compounds help control and protect the body from the potentially carcinogenic effects of certain estrogen compounds.
 
To the best of health,
 
Curt Hendrix B.S. M.S. C.C.N. C.N.S.